GSK, CureVac partnership eyes Covid-19 vaccine against multiple variants

GlaxoSmithKline and CureVac have struck a 150 million euro deal to develop next-generation vaccines against Covid-19 that target several variants.

from Top News and Analysis (pro) https://ift.tt/3oRx9gZ